Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Dearnaley

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
British Journal of Cancer|July 1, 1981
Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigenD P Dearnaley, J P Sloane, M G Ormerod, et al.
British Journal of Cancer|December 4, 1998
Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate GroupW D Dunsmuir, S M Edwards, S R Lakhani, et al.
Invasion & Metastasis|January 1, 1982
Detection of bone metastases in patients with breast cancerR C Coombes, D P Dearnaley, R Buckman, et al.
Lancet (London, England)|December 3, 1983
Detection of micrometastases in patients with primary breast cancerW H Redding, R C Coombes, P Monaghan, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancerZ Kote-Jarai, F Durocher, S M Edwards, et al.
British Journal of Cancer|October 10, 2002
HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of diseaseJ C Meitz, S M Edwards, D F Easton, et al.
British Journal of Cancer|December 6, 2000
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working PartyA Horwich, R T Oliver, P M Wilkinson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 9, 2019
Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT)E J Alexander, J R Murray, V A Morgan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 31, 2006
A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to boneJ M O'Sullivan, A R Norman, V R McCready, et al.
Pharmacogenetics|July 4, 2001
Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancerZ Kote-Jarai, D Easton, S M Edwards, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|July 1, 1981
Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigenD P Dearnaley, J P Sloane, M G Ormerod, et al.
British Journal of Cancer|December 4, 1998
Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate GroupW D Dunsmuir, S M Edwards, S R Lakhani, et al.
Invasion & Metastasis|January 1, 1982
Detection of bone metastases in patients with breast cancerR C Coombes, D P Dearnaley, R Buckman, et al.
Lancet (London, England)|December 3, 1983
Detection of micrometastases in patients with primary breast cancerW H Redding, R C Coombes, P Monaghan, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancerZ Kote-Jarai, F Durocher, S M Edwards, et al.
British Journal of Cancer|October 10, 2002
HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of diseaseJ C Meitz, S M Edwards, D F Easton, et al.
British Journal of Cancer|December 6, 2000
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working PartyA Horwich, R T Oliver, P M Wilkinson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 9, 2019
Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT)E J Alexander, J R Murray, V A Morgan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 31, 2006
A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to boneJ M O'Sullivan, A R Norman, V R McCready, et al.
Pharmacogenetics|July 4, 2001
Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancerZ Kote-Jarai, D Easton, S M Edwards, et al.
Pageof 19